HC Wainwright & Co. Maintains Buy on Korro Bio, Lowers Price Target to $15
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and lowers the price target from $20 to $15.
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and lowers the price target from $20 to $15.